Literature DB >> 23639308

Tolerated wasp sting challenge improves health-related quality of life in patients allergic to wasp venom.

Jörg Fischer, Martin Teufel, Alexandra Feidt, Katrin Elisabeth Giel, Stephan Zipfel, Tilo Biedermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23639308     DOI： 10.1016/j.jaci.2013.03.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

1.  [Sting challenge: indications and execution].

Authors:  F Ruëff; B Przybilla
Journal:  Hautarzt       Date:  2014-09       Impact factor: 0.751

2.  Honey bee venom re-challenge during specific immunotherapy: prolonged cardio-pulmonary resuscitation allowed survival in a case of near fatal anaphylaxis.

Authors:  Sara Micaletto; Kurt Ruetzler; Martin Bruesch; Peter Schmid-Grendelmeier
Journal:  Allergy Asthma Clin Immunol       Date:  2022-06-02       Impact factor: 3.373

Review 3.  Patient's Adherence and Compliance and Quality of Life During/After VIT.

Authors:  Cristoforo Incorvaia; Enrico Heffler; Silvia Peveri; Francesco Pucciarini; Giorgio Walter Canonica; Erminia Ridolo
Journal:  Front Allergy       Date:  2022-06-28

4.  Quality-of-life in insect venom allergy: validation of the Turkish version of the "Vespid Allergy Quality of Life Questionnaire" (VQLQ-T).

Authors:  Betül Ayşe Sin; Derya Öztuna; Aslı Gelincik; Feridun Gürlek; Abdullah Baysan; Aytül Zerrin Sin; Ömür Aydın; Zeynep Mısırlıgil
Journal:  Springerplus       Date:  2016-05-10

5.  A safe and efficient 7-week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom.

Authors:  Christoph Schrautzer; Lisa Arzt-Gradwohl; Danijela Bokanovic; Ines Schwarz; Urban Čerpes; Lukas Koch; Sereina Annik Herzog; Karin Laipold; Barbara Binder; Werner Aberer; Gunter Johannes Sturm
Journal:  Allergy       Date:  2019-09-03       Impact factor: 13.146

Review 6.  Clinical Utility of Rush Venom Immunotherapy: Current Status.

Authors:  Vianney Gruzelle; Claire Mailhol; David W Waters; Laurent Guilleminault
Journal:  J Asthma Allergy       Date:  2020-01-07

7.  Benefits and limitations of sting challenge in hymenoptera venom allergy.

Authors:  Katharina Aßmus; Markus Meissner; Roland Kaufmann; Eva Maria Valesky
Journal:  Allergol Select       Date:  2021-01-18

8.  Impact of specific immunotherapy and sting challenge on the quality of life in patients with hymenoptera venom allergy.

Authors:  Tamara Eitel; Kim Nikola Zeiner; Katharina Assmus; Hanns Ackermann; Nadja Zoeller; Markus Meissner; Roland Kaufmann; Stefan Kippenberger; Eva Maria Valesky
Journal:  World Allergy Organ J       Date:  2021-04-21       Impact factor: 4.084

Review 9.  Stinging insect allergy: current perspectives on venom immunotherapy.

Authors:  Sian W Ludman; Robert J Boyle
Journal:  J Asthma Allergy       Date:  2015-07-23

Review 10.  Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes.

Authors:  Simon Blank; Johannes Grosch; Markus Ollert; Maria Beatrice Bilò
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.